medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number S3

<< Back Next >>

Gac Med Mex 2004; 140 (S3)

IMPORTANCE OF THE TRANSPLANT OF CELLS PROGENITORAS HEMATOPOYÉTICAS

Importance of the fenotipo eritrocitario in the transplant de células hematopoyetics

Gómez-Morales E
Full text How to cite this article

Language: Spanish
References: 15
Page: 57-59
PDF size: 31.73 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Kalaycioglu M, Copelan E, Avalos B, et al. Survival after ABO incompatibility allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide. Bone Marrow Transplant 1995;15:105-110.

  2. Benjamin RJ, McGurk S, Ralston MS, et al. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999;39:179-187.

  3. Champlin RE, Horowitz MM, van Bekkum DW, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood 1989;73:606-613.

  4. Deeg HJ, Self S, Storb R, et al. Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: Changing impact of risk factors. Blood 1986;68:1363-1368.

  5. Schiffer CA, Anderson KC, Bennett CL et al. Platelet transfusion for patients with cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19(5):1519-1538.

  6. Salmon JP, Michaux S, Hermanne JP, et al. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion 1999;39;824-827.

  7. Sniecinski I. Management of ABO Incompatibility in Allogeneic Bone Marrow Transplantation. Chapter 35, en Forman SJ, Blume KG, Thomas ED. Bone Marrow Transplantation. 1994. Blackwell Scientific Publications. Pp 497-503.

  8. Mayer G, Wernet D, Notrthoff H, Schneider W. A simple technique of red cell removal in major ABO incompatible bone marrow transplantation. Vox Sang 1994;66:112-116.

  9. Sniecisnki I, Oien L, Petz LD, Blume KG. Immunohematologic consequences of major ABO mismatched bone marrow transplantation. Transplantation 1988;45:530-533.

  10. Benjamin RJ, Connors JM, McGurk S, et al. Prolonged erythroid aplasia after major ABO mismatched transplantation for chronic myeloid leukemia. Biol Blood Marrow Transplant 1998;4:151-156.

  11. Worel N, Greinix HT, Scneider B, et al. Regeneration of erythropoiesis after related and unrelated donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 2000;40:543-550.

  12. Leo A, Mytilineos J, Voso MT, et al. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jka after allogeneic PBPC transplantation. Transfusion 2000;40:632-636.

  13. Greeno EW, Perry EH, Ilstrup SJ, Weisdorf DJ. Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor incompatibility. Transfusion 1996;36:71-74.

  14. Dragani A, Angelini A, Iacone A, et al. Comparison of five methods for concentrating progenitor cells in human marrow transplantation. Blut 1990;60:278-281.

  15. Sniecinski I, Park HS, Nowicki B, et al. Bone marrow processing for transplantation: comparison of two authomated techniques. Transfusion 1992;32 (suppl):605.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2004;140